# A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways

> **NCT06520514** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Spesolimab

## Key facts

- **NCT ID:** NCT06520514
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-07
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-02-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520514, "A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06520514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*